22nd Century Group

22nd Century Group is a biotechnology company based in Williamsville, New York, specializing in plant biotechnology to create products that reduce the harm associated with tobacco use and promote smoking cessation. Founded in 1998, the company focuses on altering nicotine levels in tobacco through genetic engineering and plant breeding. It offers very low nicotine content (VLNC) tobacco cigarettes marketed under the Moonlight and Moonlight Menthol brands, alongside SPECTRUM research cigarettes intended for independent clinical studies. The firm is also involved in contract manufacturing for third-party branded tobacco products. Additionally, 22nd Century Group has a strategic partnership with Keygene N.V. to develop hemp and cannabis plants for various applications, including medical and agricultural uses. The company's innovative approach aims to provide consumers with healthier alternatives in tobacco products.

John Miller

President

1 past transactions

GVB Biopharma

Acquisition in 2022
GVB Biopharma, established in 2016 and based in Las Vegas, Nevada, specializes in hemp processing and cannabinoid-based consumer product manufacturing. The company operates cannabis seed testing facilities, conducting multiple tests to ensure CBD products are free from contaminants. This enables clients to create various hemp products, with a focus on organic cultivation and research-driven development of wellness solutions for global suppliers, customers, and consumers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.